000 01795 a2200529 4500
005 20250515015119.0
264 0 _c20060413
008 200604s 0 0 eng d
022 _a0008-5472
024 7 _a10.1158/0008-5472.CAN-05-1531
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKoller, Erich
245 0 0 _aUse of a chemically modified antisense oligonucleotide library to identify and validate Eg5 (kinesin-like 1) as a target for antineoplastic drug development.
_h[electronic resource]
260 _bCancer research
_cFeb 2006
300 _a2059-66 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCell Growth Processes
_xdrug effects
650 0 4 _aCell Line, Tumor
650 0 4 _aDNA, Neoplasm
_xgenetics
650 0 4 _aGene Library
650 0 4 _aGlioma
_xdrug therapy
650 0 4 _aHeLa Cells
650 0 4 _aHumans
650 0 4 _aKinesins
_xantagonists & inhibitors
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aOligonucleotides, Antisense
_xgenetics
650 0 4 _aRNA, Messenger
_xantagonists & inhibitors
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aPropp, Stephanie
700 1 _aZhang, Hong
700 1 _aZhao, Chenguang
700 1 _aXiao, Xiaokun
700 1 _aChang, MingYi
700 1 _aHirsch, Scott A
700 1 _aShepard, Peter J
700 1 _aKoo, Seongjoon
700 1 _aMurphy, Cain
700 1 _aGlazer, Robert I
700 1 _aDean, Nicholas M
773 0 _tCancer research
_gvol. 66
_gno. 4
_gp. 2059-66
856 4 0 _uhttps://doi.org/10.1158/0008-5472.CAN-05-1531
_zAvailable from publisher's website
999 _c16100424
_d16100424